Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

Journal of Gastroenterology

Volumn 47, Issue 5, 2012, Pages 561-568

  Reiberger, T ^a   Ferlitsch, A ^a   Payer, B A ^a   Pinter, M ^a   Homoncik, M ^a   Peck Radosavljevic, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

B blocker; HVPG; Liver stiffness; Portal pressure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; PROPRANOLOL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELASTOGRAPHY; FEASIBILITY STUDY; FEMALE; HEART RATE; HEMODYNAMIC MONITORING; HEPATOBILIARY PARAMETERS; HUMAN; LIVER CIRRHOSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMACH VARICES BLEEDING;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CARBAZOLES; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; FEASIBILITY STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL PRESSURE; PROPANOLAMINES; PROPRANOLOL; PROSPECTIVE STUDIES;

EID: 84865118485     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0517-4     Document Type: Article

References (22)

1. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol. 2000;32(1 Suppl):141-56. (Pubitemid 30123631)
2. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepa-tology. 2006;43(2 Suppl 1):S121-31.
3. Gatta A, Bolognesi M, Merkel C. Vasoactive factors and hemo-dynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis. Mol Aspects Med. 2008;29(1-2):119-29. (Pubitemid 351312222)
4. Blei AT, Mazhar S, Davidson CJ, Flamm SL, Abecassis M, Gheorghiade M. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome. J Clin Gastroenterol. 2007;41(Suppl 3):S323-9. (Pubitemid 350059458)
5. Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2004;20(3):254-63. (Pubitemid 38526776)
6. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(10):573-82.
7. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5(3):419-24. (Pubitemid 15065948)
8. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepa-tology. 2003;37(4):902-8. (Pubitemid 36397403)
9. Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000;32(5):930-4.
10. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cir-rhosis:asystematic review. Gastroenterology. 2006;131(5):1611-24. (Pubitemid 44708947)
11. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343-50. (Pubitemid 40439195)
12. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55(3):403-8. (Pubitemid 43268281)
13. Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008;27(12):1261-8. (Pubitemid 351697282)
14. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006;12(12):1791-8. (Pubitemid 44911805)
15. Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45(5):1290-7. (Pubitemid 46775793)
16. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elas-tography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705-13. (Pubitemid 38091720)
17. Castera L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations. Hepatology. 2010;51(3):828-35.
18. Lim JK, Groszmann RJ. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement? Hepatology. 2007;45(5):1087-90. (Pubitemid 46775769)
19. Peck-Radosavljevic M, Trauner M, Schreiber F. Austrian consensus on the definition and treatment of portal hypertension and its complications. Endoscopy. 2005;37(7):667-73. (Pubitemid 40936503)
20. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39(2):280-2. (Pubitemid 38222164)
21. Reiberger T, Rutter K, Ferlitsch A, et al. Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clin Gastroenterol Hepatol. 2011;9(7):602-8
22. Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010;52(2): 206-10.